Portugal’s California-like climate has observed a third Canadian organization appear to establish a cannabis cultivation footprint in the nation.
Initial it was Tilray, then it was Aurora and now The Flowr Corporation is set to develop cannabis in the nation. Flowr has announced plans to obtain the remaining 80% stake in Portuguese firm Holigen which has established a big cannabis operation in Aljustrel, about 100 miles south east of the capital Lisbon.
The 72-hectare internet site could grow to be one particular of the biggest cannabis facilities in the globe. Positioned in the Alentejo area it will initially generate about 500,000 kilograms of cannabis per year – and could rise to far more than 630,000 kilograms.
Cannabis Clones For Export
Flowr also announced that it has received a Well being Canada export permit that will enable it to make an initial shipment of clones from its Kelowna Campus to Portugal. It says the permits will enable the Aljustrel operation to garner its initial outside harvest later this year. Its CEO Vinay Tolia mentioned the deal is a significant milestone and a ‘cornerstone in its efforts to service the worldwide healthcare cannabis market’.
“Aljustrel is one particular of the biggest outside THC cultivation licenses in the created globe, and will be instrumental in supplying substantial-scale, low-price cannabis extract for pharmaceutical APIs, as properly as oils to service the European healthcare markets.”
Best Climatic Cannabis Situations
Flowr, which is primarily based in Toronto, builds and operates substantial-scale, GMP-created cultivation facilities and not too long ago announced plans to raise up to C$125 million to finalize the Holigen buy. 1 of Portugal’s significant attractions for such foreign businesses is that it has best climatic and cultivation circumstances.
It represents an appealing industry, with comparatively low labor expenses and and a current adjust in the law makes it possible for for the distribution of healthcare cannabis to other EU nations, exactly where it is legal. Edmonton-primarily based Aurora has signed an agreement to obtain a 51% ownership stake in Gaia Pharma, a Portuguese-primarily based organization with plans to generate healthcare cannabis and derivative items.
Aurora mentioned building of the initial phase of the Gaia facility, capable of generating up to two,000 kilograms of cannabis a year, was anticipated to be completed in late 2020.